Trial intelligence / Profile preview

Tranexamic Acid in Meningioma Resection

NCT05230381Unknown

Sponsor
Beijing Tiantan Hospital
Start
Jun 2022
Primary completion
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of tranexamic acid in intraoperative hemorrhage (3 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Estimated intra-operative blood loss. Status: unknown.

02

Drugs

tranexamic acid
03

Conditions

intraoperative hemorrhage

Beyond the preview

Go deeper on NCT05230381.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05230381.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call